Stay updated on Atezolizumab Subq in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.

Latest updates to the Atezolizumab Subq in NSCLC: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now includes a mention of the 2018 NIH Grant/Contract and updates the revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now displays a generic 'An error occurred' message and HTML, replacing the previous study record content. This indicates a temporary outage or server error rather than an update to the study data.SummaryDifference18%

- Check51 days agoChange DetectedThe page revision changed from v3.6.3 to v3.6.4, indicating a minor update to the page's version metadata. This update does not alter any study details, eligibility criteria, or results on the page.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded a new publication citation for subcutaneous vs intravenous atezolizumab in NSCLC and removed the prior online-ahead-of-print citation, updating the referenced literature in the Publications section.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision label on the page has been updated from v3.6.0 to v3.6.2, indicating a minor update to the page template or content rather than to the study information.SummaryDifference0.0%

- Check93 days agoChange DetectedThe Intervention/Treatment section label is updated and new guidance sections such as How to Read a Study Record, Common Questions, and How to Join a Study have been added, while a status line No longer looking for participants appears on the page.SummaryDifference0.2%

Stay in the know with updates to Atezolizumab Subq in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.